ATOS - CIK 0001488039
The table below shows ATOSSA THERAPEUTICS, INC.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $41.30M | $71.08M | $88.46M | $110.89M | $136.38M | $39.55M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $45.62M |
| $74.46M |
| $92.22M |
| $118.20M |
| $141.24M |
| $42.77M |
| Property, plant & equipment | - | - | - | - | $20.00K | $20.63K |
| Goodwill | - | - | - | - | - | - |
| Total assets | $47.61M | $76.44M | $96.25M | $123.53M | $141.26M | $42.84M |
| Accounts payable | $4.29M | $679.00K | $806.00K | $2.96M | $1.72M | $1.59M |
| Total current liabilities | $8.26M | $4.97M | $5.24M | $5.57M | $3.13M | $15.67M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $8.26M | $4.97M | $5.24M | $5.57M | $3.13M | $15.67M |
| Retained earnings | -$246.56M | -$211.79M | -$186.29M | -$156.19M | -$129.23M | -$111.90M |
| Total equity | $39.35M | $71.48M | $91.02M | $117.96M | $138.14M | $27.17M |